Phase 4 Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Subjects Aged > =18 Years With Severe Eosinophilic Asthma Requiring Maintenance Oral Corticosteroids
Condition: Asthma Interventions: Drug: Prednisone/ Prednisolone; Biological: Mepolizumab; Drug: Salbutamol Sponsors: GlaxoSmithKline; Tech Observer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asthma | Corticosteroid Therapy | India Health | Prednisolone | Prednisone | Research | Study